Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Microdoses of Ranibizumab in Diabetic Macular Edema - the MINIMA 2 Study

NCT01112085 is registered in ClinicalTrials.gov with Especialistas en Retina Medica y Quirurgica Grupo de Investigacion as lead sponsor.

NCT NCT01112085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01112085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Microdoses of Ranibizumab in Diabetic Macular Edema - the MINIMA 2 Study
Lead sponsor
Especialistas en Retina Medica y Quirurgica Grupo de Investigacion
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2010
Completion date
June 30, 2014
Enrollment
72 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema